PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for March 10, 2004 Subscribe to this News Feed    
 

New 2004 BioMoney Directory is Now Available The #1 Source to Identify and Contact Life Science Investors

The new 2004 edition of the BioMoney Directory has just been released. It provides biomed entrepreneurs with over 675 equity capital funding sources.

Nesconset, NY (PRWEB) March 10, 2004 -- The new 2004 edition of the BioMoney Directory -- Funding Sources for Life Science Companies Seeking Capital - is now available from MaxiVest Ltd.

The 208-page volume provides contact information on more than 675 venture capitalists, private equity management firms, corporate investors and more -- in the US, Europe, Israel and Asia. Readers of the BioMoney Directory can learn who funds the life sciences, what they look for, their geographic preferences and how much they invest.

Joel Bailey, publisher of the BioMoney Directory, said At this time, when funding for the life sciences is difficult to locate, the BioMoney Directory can help entrepreneurs quickly pinpoint investors that are interested in their particular niche. The Directory can save users enormous time and expense in searching for the right investors."

The BioMoney Directory can be ordered from the BioMoney Directory Website: www.biomoneydir.com for just $75.
      
For additional information, please visit the BioMoney Directory Website.

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Joel Bailey
MAXIVEST LTD.
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.